Recombinant Factor 9 was licensed and the funding arrangements in England mirrored those for Factor 8. Linked evidence WITN4505216 - Memorandum from Mike McGovern to Sheila Adam - 04 Jan 1999 Chronology Information Date: 1 January 1999 Chapter/issue Access to Treatment